How does Teladoc Health (TDOC) make money?

Teladoc Health (TDOC) generates revenue primarily from Other.., which accounted for 100% of total revenue in TTM through Q1 2026. The company reported $2.51B in revenue and converted -6.8% of it into net profit, equivalent to roughly −$171.15M in net income — what's left after the cost of revenue, operating expenses, interest, and income taxes.

What is the gross profit margin of Teladoc Health (TDOC)?

Teladoc Health (TDOC) reported a gross profit margin of 65.6% in TTM through Q1 2026, equivalent to $1.65B in gross profit on $2.51B in revenue. Gross margin measures how much of each dollar of revenue remains after the direct cost of producing or delivering the product — a higher figure typically signals pricing power, scale, or a less capital-intensive business model.

What is the operating profit margin of Teladoc Health (TDOC)?

Teladoc Health (TDOC) reported an operating profit margin of -7.6% in TTM through Q1 2026, equivalent to −$191.07M in operating income. Operating margin captures profitability after research & development, sales & marketing, and general & administrative expenses — but before interest, taxes, and one-off items — and is the cleanest single read on the underlying business's efficiency.

What is the net profit margin of Teladoc Health (TDOC)?

Teladoc Health (TDOC) reported a net profit margin of -6.8% in TTM through Q1 2026, equivalent to −$171.15M in net income. Net margin is the bottom-line share of revenue that survives every expense — operating costs, interest, and income taxes — and is the figure that flows directly into earnings per share.

Is Teladoc Health (TDOC) profitable?

Teladoc Health (TDOC) reported a net loss of $171.15M for TTM through Q1 2026, a net profit margin of -6.8%. Combined operating expenses, interest, and income taxes exceeded revenue, so the period closed in the red on a reported basis.

How much does Teladoc Health (TDOC) invest in research and development?

Teladoc Health (TDOC) invested $320.12M in research and development during TTM through Q1 2026, roughly 12.7% of total revenue. R&D spending funds the company's future product pipeline and is expensed in full on the income statement rather than capitalised, which makes the operating margin sensitive to how aggressively management chooses to reinvest in innovation.

How much does Teladoc Health (TDOC) spend on capital expenditures?

Teladoc Health (TDOC) spent $36.87M on capital expenditures (CapEx) during TTM through Q1 2026, roughly 1.5% of total revenue. CapEx represents long-lived investment in property, equipment, data centres, and other physical infrastructure, and is subtracted from operating cash flow to arrive at free cash flow.

How much free cash flow does Teladoc Health (TDOC) generate?

Teladoc Health (TDOC) generated $251.09M in free cash flow during TTM through Q1 2026, a free-cash-flow margin of 10.0%. Free cash flow is the cash left after capital expenditures and represents the discretionary pool the company can use to pay dividends, repurchase shares, repay debt, or fund acquisitions without raising external capital.

Where does Teladoc Health (TDOC) generate most of its revenue?

UNITED STATES is the largest geographic market for Teladoc Health (TDOC), accounting for 81.1% of revenue in the most recent annual filing. The complete regional split — including international markets and any Rest-of-World rollup — is shown in the revenue-by-geography table on this page.

How Teladoc Health Makes Money: 2026 Visual Revenue Map

Teladoc Health (TDOC) Income Statement Flow — TTM through Q1 2026

Calculated from the four most recent reported quarters, ending March 31, 2026 (reported April 30, 2026).

Teladoc Health (TDOC) Revenue by Geography — TTM through Q1 2026

Aggregated from the four quarterly disclosures behind this TTM. Minor differences vs the company's annual filing can occur if reported regions changed mid-year.

Revenue contribution by geographic region for Teladoc Health (TDOC), TTM through Q1 2026
Region	Revenue (USD)	% of total
UNITED STATES	$2.04B	81.1%
Non-US	$476.18M	18.9%
Total	$2.51B	100%

UNITED STATES
Non-US
Total

Revenue Breakdown — TTM through Q1 2026

In TTM through Q1 2026, Teladoc Health (TDOC) generated 81.1% of revenue from UNITED STATES, followed by Non-US (18.9%).

Frequently asked questions

Data & methodology

Teladoc Health (TDOC) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview

TDOC Overview

Counters

Income Statement

Cash Flow

Capital Return

Buybacks

No dividends or stock splits on record for this company.

Forecast & Valuation

Teladoc Health (TDOC) Income Statement Flow — TTM through Q1 2026

Teladoc Health (TDOC) Revenue by Geography — TTM through Q1 2026

Revenue Breakdown — TTM through Q1 2026

Frequently asked questions

+How does Teladoc Health (TDOC) make money?

+What is the gross profit margin of Teladoc Health (TDOC)?

+What is the operating profit margin of Teladoc Health (TDOC)?

+What is the net profit margin of Teladoc Health (TDOC)?

+Is Teladoc Health (TDOC) profitable?

+How much does Teladoc Health (TDOC) invest in research and development?

+How much does Teladoc Health (TDOC) spend on capital expenditures?

+How much free cash flow does Teladoc Health (TDOC) generate?

+Where does Teladoc Health (TDOC) generate most of its revenue?

Data & methodology

+What is a Sankey diagram?

+How is the data calculated?

+Where do segment and geographic numbers come from?

+When was this data last updated?

Teladoc Health (TDOC) Key Financials

Explore more